Michael Böhm Selected Research

Patient Readmission

1/2022	Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.
1/2022	Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.
12/2021	Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.
1/2019	Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial.
1/2019	Effects of Serelaxin in Patients with Acute Heart Failure.
1/2017	Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction Program.
3/2015	Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.
3/2013	Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
3/2013	Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.
6/2009	Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Böhm Research Topics

Disease

258	Heart Failure 04/2024 - 02/2002
163	Hypertension (High Blood Pressure) 04/2024 - 01/2002
45	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 02/2002
44	Atrial Fibrillation 03/2024 - 06/2003
42	Myocardial Infarction 10/2023 - 06/2002
40	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 03/2002
37	Fibrosis (Cirrhosis) 12/2023 - 02/2002
32	Systolic Heart Failure 01/2023 - 11/2007
30	Atherosclerosis 01/2021 - 12/2002
25	Stroke (Strokes) 10/2023 - 06/2002
24	Inflammation (Inflammations) 12/2023 - 07/2002
22	Cardiogenic Shock 01/2021 - 08/2007
21	Cardiomyopathies (Cardiomyopathy) 12/2023 - 10/2002
18	Type 2 Diabetes Mellitus (MODY) 03/2024 - 03/2008
18	Left Ventricular Dysfunction 04/2022 - 02/2002
16	Shock 05/2024 - 03/2004
16	Chronic Renal Insufficiency 04/2024 - 08/2013
15	Hypertrophy 01/2022 - 09/2002
12	Cardiomegaly (Heart Hypertrophy) 10/2022 - 02/2002
10	Thrombosis (Thrombus) 10/2023 - 02/2003
10	Vascular Diseases (Vascular Disease) 10/2023 - 08/2006
10	Diabetes Mellitus 01/2018 - 10/2008
9	Heart Diseases (Heart Disease) 04/2024 - 09/2002
9	COVID-19 03/2024 - 12/2020
9	Body Weight (Weight, Body) 08/2023 - 09/2002
9	Erectile Dysfunction 01/2023 - 05/2003
9	Hypotension (Low Blood Pressure) 11/2022 - 07/2010
9	Coronary Disease (Coronary Heart Disease) 10/2017 - 03/2002
8	Myocarditis (Carditis) 10/2022 - 01/2003
8	Hemorrhage 01/2021 - 01/2008
8	Infarction (Infarctions) 01/2021 - 02/2002
8	Acute Coronary Syndrome 03/2017 - 02/2002
7	Chronic Kidney Failure (Chronic Renal Failure) 11/2022 - 01/2009
6	Ischemic Stroke 01/2023 - 06/2002
6	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2008
6	Dyslipidemias (Dyslipidemia) 01/2022 - 08/2009
6	Ventricular Remodeling 01/2021 - 12/2004
6	Atherosclerotic Plaque (Atheroma) 01/2020 - 05/2008
6	Bradycardia 12/2016 - 09/2009
6	Essential Hypertension 01/2016 - 01/2004

Drug/Important Bio-Agent (IBA)

47	IvabradineIBA 10/2023 - 01/2007
38	Antihypertensive Agents (Antihypertensives)IBA 02/2024 - 09/2010
35	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 02/2002
26	empagliflozinIBA 03/2024 - 01/2019
25	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 10/2007
25	DiureticsIBA 09/2023 - 06/2003
24	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2004
24	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2022 - 01/2002
23	salicylhydroxamic acid (SHAM)IBA 04/2024 - 03/2002
18	Ramipril (Altace)FDA LinkGeneric 01/2021 - 02/2002
16	Telmisartan (Micardis)FDA Link 01/2021 - 09/2006
16	CholesterolIBA 12/2019 - 06/2002
14	SodiumIBA 12/2023 - 12/2012
13	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2002
13	Mineralocorticoid Receptor AntagonistsIBA 09/2023 - 06/2009
12	Rosuvastatin Calcium (Crestor)FDA Link 06/2014 - 06/2002
11	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2024 - 04/2007
11	Indicators and Reagents (Reagents)IBA 11/2023 - 04/2009
11	pro-brain natriuretic peptide (1-76)IBA 08/2023 - 05/2006
11	CreatinineIBA 01/2023 - 11/2005
11	dapagliflozinIBA 01/2022 - 11/2019
11	LipidsIBA 01/2021 - 03/2002
10	Sodium-Glucose Transport ProteinsIBA 03/2024 - 11/2019
10	CollagenIBA 01/2020 - 03/2007
10	Nebivolol FDA Link 01/2015 - 11/2002
9	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2023 - 04/2010
9	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2023 - 09/2010
9	Neprilysin (Neutral Endopeptidase)IBA 09/2023 - 01/2015
9	Angiotensin Receptor AntagonistsIBA 11/2022 - 01/2002
9	Natriuretic PeptidesIBA 10/2022 - 01/2015
9	Messenger RNA (mRNA)IBA 01/2020 - 05/2002
9	Angiotensin IIIBA 06/2010 - 03/2002
8	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 11/2019
8	Eplerenone (Inspra)FDA LinkGeneric 11/2022 - 07/2010
8	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 04/2002
8	ReninIBA 01/2021 - 02/2002
8	AldosteroneIBA 10/2016 - 03/2002
7	Apolipoproteins E (ApoE)IBA 10/2022 - 10/2006
7	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 10/2003
7	aliskiren FDA Link 01/2018 - 11/2010
7	Adrenergic Agents (Adrenergic Drugs)IBA 05/2013 - 03/2002
7	erucylphosphocholineIBA 05/2011 - 01/2004
6	omecamtiv mecarbilIBA 09/2023 - 11/2020
6	AnticoagulantsIBA 06/2023 - 02/2008
6	Interleukin-6 (Interleukin 6)IBA 07/2015 - 02/2002
6	C-Reactive ProteinIBA 08/2014 - 02/2002
6	Atrial Natriuretic Factor (ANF)IBA 03/2013 - 03/2002
5	Triglycerides (Triacylglycerol)IBA 10/2023 - 08/2014

Therapy/Procedure

156	Therapeutics 03/2024 - 01/2002
108	Denervation 04/2024 - 12/2010
51	Catheters 04/2024 - 05/2009
41	Sympathectomy (Sympathectomies) 04/2024 - 12/2010
11	Drug Therapy (Chemotherapy) 02/2023 - 08/2007
11	Stents 07/2020 - 04/2003
10	Patient Readmission 01/2022 - 06/2009
9	Heart Transplantation (Grafting, Heart) 11/2021 - 08/2008
9	Percutaneous Coronary Intervention 01/2021 - 01/2008
7	Secondary Prevention 01/2024 - 04/2003
6	Electrodes (Electrode) 05/2024 - 07/2005
6	Aftercare (After-Treatment) 12/2016 - 09/2006